AR and prostate carcinoma: In contrast, after 24 h of treatment with UBX‐390, the levels of proteins associated with the AR and prostate cancer signaling pathways were downregulated compared to those observed after treatment with dimethyl sulfoxide (DMSO) (Figure 2B).